Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Guiu

Showing results (161-170 of 241) with videos related to

Pageof 25
Sort By:
Journal of Hepatology|December 15, 2010
Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in miceAnne Laure Sberna, Mahfoud Assem, Thomas Gautier, et al.
Cancer Treatment Reviews|July 12, 2021
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysisJulien Edeline, Angela Lamarca, Mairéad G McNamara, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2022
Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular CarcinomaAstrid Herrero, Lucile Boivineau, Gianluca Cassese, et al.
European Radiology|June 11, 2015
Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicinMathieu Boulin, Antonin Schmitt, Elisabeth Delhom, et al.
Gut|October 20, 2009
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerBoris Guiu, Jean Michel Petit, Franck Bonnetain, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Hepatobiliary Scintigraphy and Glass <sup>90</sup>Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated LiverCarole Allimant, Emmanuel Deshayes, Marilyne Kafrouni, et al.
Hepatology Communications|April 16, 2021
Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After AblationMargaux Hermida, Ancelin Preel, Eric Assenat, et al.
Acta Diabetologica|May 16, 2015
GCKR polymorphism influences liver fat content in patients with type 2 diabetesJean-Michel Petit, David Masson, Boris Guiu, et al.
Atherosclerosis|September 11, 2012
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetesMarie-Claude Brindisi, Boris Guiu, Laurence Duvillard, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 16, 2018
Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular CarcinomaCarole Allimant, Marilyne Kafrouni, Julien Delicque, et al.
Pageof 25

Showing results (161-170 of 241) with videos related to

Sort By:
Pageof 25
Journal of Hepatology|December 15, 2010
Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in miceAnne Laure Sberna, Mahfoud Assem, Thomas Gautier, et al.
Cancer Treatment Reviews|July 12, 2021
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysisJulien Edeline, Angela Lamarca, Mairéad G McNamara, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2022
Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular CarcinomaAstrid Herrero, Lucile Boivineau, Gianluca Cassese, et al.
European Radiology|June 11, 2015
Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicinMathieu Boulin, Antonin Schmitt, Elisabeth Delhom, et al.
Gut|October 20, 2009
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerBoris Guiu, Jean Michel Petit, Franck Bonnetain, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Hepatobiliary Scintigraphy and Glass <sup>90</sup>Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated LiverCarole Allimant, Emmanuel Deshayes, Marilyne Kafrouni, et al.
Hepatology Communications|April 16, 2021
Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After AblationMargaux Hermida, Ancelin Preel, Eric Assenat, et al.
Acta Diabetologica|May 16, 2015
GCKR polymorphism influences liver fat content in patients with type 2 diabetesJean-Michel Petit, David Masson, Boris Guiu, et al.
Atherosclerosis|September 11, 2012
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetesMarie-Claude Brindisi, Boris Guiu, Laurence Duvillard, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 16, 2018
Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular CarcinomaCarole Allimant, Marilyne Kafrouni, Julien Delicque, et al.
Pageof 25